Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Objective: to demonstrate that buccal misoprostol administration during cesarean delivery in
women with risk factors for uterine atony decreases the need for additional uterotonic
medications, uterine atony and postpartum hemorrhage.
Design: randomized, double-blinded, placebo-controlled trial.